Search for Clinical Trial Results

Sponsored By

Red-Cell Aplasia, Pure - 25 Studies Found

Status Study
Completed Study Name: A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins
Condition: Red-Cell Aplasia, Pure
Date: 2005-09-13
Completed Study Name: A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment
Condition: Pure Red-cell Aplasia
Date: 2005-09-13
Interventions: Other: No intervention This is an observational study. No medication will be given to the participants.
Completed Study Name: Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin
Condition:
  • Red-Cell Aplasia, Pure
  • Chronic Renal Failure

Date: 2005-09-13
Interventions: Other: No Intervention Participants will not receive any intervention in this study. Participants with c
Enrolling by invitation Study Name: Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa
Condition:
  • Red-Cell Aplasia, Pure
  • Renal Insufficiency, Chronic

Date: 2016-01-05
Interventions: Procedure: Pure Red Cell Aplasia diagnostic confirmation P
Completed Study Name: A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
Condition: Pure Red-cell Aplasia
Date: 2005-09-13
Interventions: Drug: No intervention This study is an observational study. No medication will be provided or administer
Completed Study Name: Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Condition:
  • Anemia, Aplastic
  • Red-Cell Aplasia, Pure
  • Pure Red-Cell Aplasia
  • Chronic Kidney Failure

Date: 2006-10-20
Terminated Study Name: A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Condition:
  • Aplastic Anemia
  • Pure Red Cell Aplasia
  • Anemia
  • Chronic Kidney Disease
  • Chronic Renal Failure
    • <
    Date: 2006-04-13
    Interventions: Drug: peginesatide Other Names:
    • Omontys
    • Hematide
    • AF37
Completed Study Name: Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
Condition:
  • Neutropenia
  • Sickle Cell Anemia
  • Thalassemia Major
  • Date: 2000-06-02
    Interventions:
    • Drug: anti-thymocyte globulin
    • Drug: busulf
Next >>>